Fox Run Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,349
Closed -$1.58M 1144
2025
Q3
$1.58M Buy
+12,349
New +$1.51M 0.25% 74
2025
Q2
Sell
-17,840
Closed -$1.99M 1111
2025
Q1
$1.99M Buy
17,840
+3,351
+23% +$357K 0.31% 29
2024
Q4
$1.41M Sell
14,489
-158
-1% -$16.8K 0.26% 67
2024
Q3
$1.68M Buy
14,647
+12,156
+488% +$1.38M 0.37% 11
2024
Q2
$265K Buy
+2,491
New +$250K 0.05% 582
2023
Q3
Sell
-5,915
Closed -$597K 901
2023
Q2
$597K Buy
+5,915
New +$592K 0.17% 237
2023
Q1
Sell
-3,572
Closed -$324K 847
2022
Q4
$324K Sell
3,572
-5,694
-61% -$480K 0.13% 313
2022
Q3
$704K Buy
9,266
+1,880
+25% +$156K 0.27% 76
2022
Q2
$624K Buy
+7,386
New +$648K 0.31% 67
2021
Q3
Sell
-3,920
Closed -$358K 574
2021
Q2
$358K Buy
+3,920
New +$349K 0.33% 115
2020
Q3
Sell
-2,385
Closed -$208K 275
2020
Q2
$208K Buy
+2,385
New +$206K 0.28% 203
2019
Q4
Sell
-5,316
Closed -$462K 485
2019
Q3
$462K Buy
+5,316
New +$477K 0.42% 49
2019
Q1
Sell
-6,940
Closed -$534K 628
2018
Q4
$534K Sell
6,940
-419
-6% -$32.6K 0.28% 90
2018
Q3
$568K Buy
+7,359
New +$544K 0.25% 136
2017
Q4
Sell
-4,910
Closed -$378K 815
2017
Q3
$378K Sell
4,910
-335
-6% -$25.3K 0.11% 400
2017
Q2
$392K Buy
+5,245
New +$372K 0.14% 318
2016
Q4
Sell
-4,241
Closed -$300K 619
2016
Q3
$300K Sell
4,241
-2,567
-38% -$187K 0.18% 247
2016
Q2
$503K Buy
6,808
+2,344
+53% +$162K 0.24% 124
2016
Q1
$290K Buy
+4,464
New +$304K 0.19% 236

Other funds holding NVS